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Northern blot analysis demonstrated that the concentration of mosltol 1.4,5-trisphosphate (IP,) receptor mRNA was greatest m cerebellar tissue. 
Moderate amounts of IP, mRNA were present m brain tissue without cerebellum and ttssue of the thymus, heart. lung, liver, spleen, kidney, and 
uterus. Small amounts of IP, receptor mRNA were observed m skeletal muscle and testicular tissue. Regional distribution of IP, mRNA in various 
tissues was also exammed by m situ hybridization. A constderable amount of IP, receptor mRNA was located in smooth muscle cells, such as 
those of the arteries, bronchtoles. ovtduct and uterus. In addttion, secondary oocytes surrounded by Graafian follicles m the ovary were found 
to have large amounts of IP, receptor mRNA. The present studies suggest a functional importance of the IP, second-messenger system in these 
cell types. 
Inositol 1.4.5trisphosphate receptor; Second messenger; Cerebellum, Smooth muscle: Oocyte; Hybridization, m situ 
1. INTRODUCTION 
The phosphatidylinositide (PI)-dependent signal 
transduction pathway is now considered to play an im- 
portant role in controlling the functions of a variety of 
cell types [l]. The physiological action of hormones, 
neurotransmitters and growth factors triggers receptor- 
activated PI hydrolysis by activating the conversion en- 
zyme phospholipase C. This is the primary event of 
transmembrane signalling by which these extracellular 
signals are translated into two intracellular second 
messengers, inositol 1,4,5trisphosphate (IP3) and 
1,2-diacylglycerol (DAG). These second messengers are 
known to lead to cellular responses: IP3 contributes to 
the release of Ca2+ into the cytoplasm from in- 
tracellular Ca2+ storage sites such as the endoplasmic 
reticulum (ER) while DAG activates protein kinase C. 
localization of IP3 receptor mRNA in many tissues, us- 
ing hybridization techniques. All tissues tested possess- 
ed the IP3 receptor mRNA. Our results show that a 
considerable amount of IP3 receptor mRNA is general- 
ly present in smooth muscle cells, which seems to relate 
to the fact that IP3 can stimulate smooth-muscle con- 
traction by inducing CaZf release from the sar- 
coplasmic reticulum (SR) [8,9]. We also observed large 
amounts of IP3 receptor mRNA in secondary oocytes 
in which IP3 may induce Ca2+ release, an event known 
to occur in Xenopus oocytes [lo]. 
2. MATERIALS AND METHODS 
The second messenger IP3 must bind to a specific II’3 
receptor [2,3], before Ca2+ is released [4,5] from the in- 
tracellular Ca2+ storage sites. The primary structure of 
the IP3 receptor protein was recently determined by 
cloning its cDNA from a cDNA library of the mouse 
cerebellum [6,7]. In order to understand its functional 
importance, we have now examined the expression and 
Sixty-day-old mice (ICR) were used. 
Poly(A)+ RNA preparation and Northern blot hybridization were 
performed as previously described [7]. 
For in situ hybridization, paraffin sections from various tissues 
(6 pm) were prepared and hybridized with 35S-labeled probes essen- 
tially as previously reported [ll]. After the hybridization reaction, 
the sections were dipped in NTB2 nuclear track emulsion (Kodak, 
USA) and autoradiography was performed [ll]. The sections were 
lightly stained with 0.1% Cresyl vtolet (Merck, FRG) and examined 
by light microscopy. 
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A hybridization probe was prepared by random-primed labeling of 
the 1Pj receptor cDNA with Klenow enzyme (Takara Shuzo, Japan) 
and [cu-j5S]dCTP (Amersham, UK) [7]. pUC118 vector DNA, 
linearized with restriction endonuclease EcoRI (Takara Shuzo) and 
‘5S-labeled, was used as a non-specific DNA probe. 
3. RESULTS AND DISCUSSION 
Abbreviatrons: IPs, inositol 1,4,5_trisphosphate; PI, 
phosphoinositide; DAG, 1,2-diacylglycerol; ER, endoplasmic 
reticulum; SR, sarcoplasmic reticulum 
Our results show that the IP3 receptor is extraor- 
dinarily abundant in the mouse cerebellum. Fig. 1 
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Fig 1. Northern blot hybrtdlzation analysis. (A) 5,ug of poly(A)* 
RNAs per lane except for cerebellum (IJ’IO), 0.5 &lane, were 
hybridized with the IP3 receptor cDNA probe (B) ‘I’he \arne bIot was 
probed with the $-awn cDNA as a control. 
clearly shows that the IP3 receptor mRNA is enriched 
in the cerebellum, having a concentration dozens of 
times greater than in any other brain area or in the 
peripheral tissues tested (lanes 1 and 2). We previously 
localized the quantitatively predominant sites of IP3 
receptor in cerebe!lar Purkinje neurons by im- 
munoh~stochemical and in situ hybridization 
histochemical analyses [3,7]. The transcriptionally ac- 
tive expression of IP3 receptor suggests the importance 
of PI turnover in this neuron. For example, it is sug- 
gested that synaptic transmission between Purkinje 
neurons and granule neurons may be mediated by a 
quisqualate-preferring glutamate receptor coupled with 
the PI turnover system [12,13]. There have been 
numerous recent reports on the existence of the PI tur- 
nover system in a variety of tissues. Our results indicate 
that all tissues tested thus far have the IPJ receptor 
mRNA (Fig. I), suggesting its importance in basic 
cellular function of all cell or tissue types, in addition 
to its cell-specific roles. Moderate amounts of IPx 
receptor mRNA were present in tissue of the brain 
without cerebellum and in tissue of the thymus, heart, 
lung, liver, spleen, kidney and uterus. However, we 
detected only a small amount of fP3 receptor mRNA in 
skeletal muscle and testicular tissue. 
Figs 2 and 3 show the results of in situ hybridization 
with tissue sections. In kidney sections (Fig. 2), arteries 
were visualized as strongly hybridizing sites while veins 
Fig. 2. Localization of the IP? receptor mRNA in the kidney sections, 
Darh-field (A, B and D) and bright-field (E) autoradiograms of 
mouse kidney sections hybridized alth the ZiS-iabelcd JPi receptor 
cDNA. (C) Bright-field photo of the hemato~~lin/co~~n-staIned 
section adjacent to the section (8). (D) and (E) arc the \ame section. 
IA, tnterlobar arter); IV, mtcriobar \e%n: AA, arcua[e artery: A\‘, 
also produced a positive signal. Mesangium cells in 
glomeruli, in which the PI turnover system is known to 
occur 114,151, did not produce obvious hybridization 
signals. In lung sections, bronchioles were strongly 
labeled while arteries were also labeled (data not 
shown). These data indicate that vascular and bron- 
chial smooth muscles possess large amounts of IP3 
receptor. This result may relate to recent findings that 
endothelin, a peptide released from endothelial cells 
1161 and renal and tracheal epithelial cells [17,18], acts 
as a potent vasoconstrictor and bronchoconstrictor, in 
a manner similar to that of angiotensin II, by 
stimulating the PI turnover system [19]. Strongly- 
labeled regions were also observed in the oviduct and 
uterus sections (Fig. 3), especially the smooth-muscle 
cell layers of both tissues, the tunica muscularis of the 
oviduct, and the myometrium of the uterus. Smooth- 
muscle contraction is generally thought to be activated 
by IPj-induced Ca’+ released from the SR [8,9,20]. Our 
results show that smooth muscles generally possess 
quantitatively large amounts of IP3 receptor which pro- 
bably functions as one of the suppliers of Ca’+ which 
is required for the activation of smooth-muscle con- 
traction. In contrast with smooth muscle, skeletal mus- 
cle had a weak expression of IP3 receptor (Fig. 1). 
Recently, we reported the amino acid sequence 
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Fig. 3. Localization of the IP3 receptor mRNA in the ovary, oviduct and uterus sections. Bright-field (A and D) and dark-field (B, C, E and 
F) autoradiograms. (A), (B), (D) and (E) sections were hybridized with the IPr receptor cDNA probe, and (C) and (F) with the pUCll8 probe 
as a control. Ov, ovary; Od, oviduct; Ut, uterus; 0 2, secondary oocyte; GF, Graafian follicle. 
homology of the IP3 receptor with the ryanodine recep- 
tor found in large quantities in skeletal muscle [7,21]. 
IP3 and ryanodine receptors are involved in Ca’+ 
release from the ER and SR, respectively. Therefore, 
the ryanodine receptor is found predominantly in, and 
is responsible for, skeletal muscle contraction, whereas 
the IP3 receptor may be primarily involved in a 
regulatory cellular response. Our data show that the 
testis has only a small amount of IP3 receptor mRNA 
(Fig. 1). However, Nordquist et al. [22] reported that in 
testis the intensity of mRNA bands hybridizing to 
PCD6 clone, which is part of the IP3 receptor cDNA, 
appeared to be almost the same as that in kidney tissue. 
With regard to this discrepancy, we believe that the 
testis preparation of Nordquist et al. [22] contained the 
ductus deferens (= vas deferens) which is composed of 
smooth muscle, while our preparation did not. In ovary 
sections (Fig. 3), large amounts of IP3 receptor mRNA 
were observed in the secondary oocytes (02) within the 
Graafian follicles. IPJ-induced Ca2+ release is known 
to occur in Xenopus oocytes [lo]. At this stage mature 
oocytes may prepare for the IP3-induced Ca2+ release 
associated with fertilization which may be required for 
the egg-induced modification of the zona pellucida that 
results in the polyspermy block [23]. 
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